Literature DB >> 15243812

Rituximab in children with idiopathic thrombocytopenic purpura: does it really work?

Giovanna Russo, Maria Licciardello, Milena La Spina.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15243812     DOI： 10.1007/s00431-004-1498-6

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  1 in total

1.  Successful treatment with the monoclonal antibody rituximab in two children with refractory autoimmune thrombocytopenia.

Authors:  Anna Pusiol; Simone Cesaro; Agostino Nocerino; Giorgio Picco; Luigi Zanesco; Gianni Bisogno
Journal:  Eur J Pediatr       Date:  2004-06       Impact factor: 3.183
  1 in total
  3 in total

1.  Rituximab treatment in refractory idiopathic thrombocytopenic purpura in children.

Authors:  Jelena Roganovic
Journal:  Eur J Pediatr       Date:  2005-02-15       Impact factor: 3.183

Review 2.  Treatment with rituximab in benign and malignant hematologic disorders in children.

Authors:  Lisa B Giulino; James B Bussel; Ellis J Neufeld
Journal:  J Pediatr       Date:  2007-04       Impact factor: 4.406

3.  Rituximab (anti-CD20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment.

Authors:  Emilia Parodi; Bruno Nobili; Silverio Perrotta; Sofia Maria Rosaria Matarese; Giovanna Russo; Maria Licciardello; Marco Zecca; Franco Locatelli; Simone Cesaro; Gianni Bisogno; Paola Giordano; Domenico De Mattia; Ugo Ramenghia
Journal:  Int J Hematol       Date:  2006-07       Impact factor: 2.490
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.